These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

989 related articles for article (PubMed ID: 12021923)

  • 1. Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone.
    Masi L; Malentacchi C; Campanacci D; Franchi A
    Virchows Arch; 2002 May; 440(5):491-7. PubMed ID: 12021923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
    Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA
    Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of TGF-beta1, TGF-beta2, TGF-beta3 and the receptors TGF-betaRI and TGF-betaRII in placentomes of artificially inseminated and nuclear transfer derived bovine pregnancies.
    Ravelich SR; Shelling AN; Wells DN; Peterson AJ; Lee RS; Ramachandran A; Keelan JA
    Placenta; 2006; 27(2-3):307-16. PubMed ID: 15955560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of transforming growth factor beta isoforms and their receptors in malignant fibrous histiocytoma of soft tissues.
    Yamamoto T; Akisue T; Marui T; Fujita I; Matsumoto K; Hitora T; Kawamoto T; Nagira K; Nakatani T; Kurosaka M
    Clin Cancer Res; 2004 Sep; 10(17):5804-7. PubMed ID: 15355909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid closure of midgestational excisional wounds in a fetal mouse model is associated with altered transforming growth factor-beta isoform and receptor expression.
    Goldberg SR; McKinstry RP; Sykes V; Lanning DA
    J Pediatr Surg; 2007 Jun; 42(6):966-71; discussion 971-3. PubMed ID: 17560204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of transforming growth factor beta isoforms in osteosarcoma variants: association of TGF beta 1 with high-grade osteosarcomas.
    Franchi A; Arganini L; Baroni G; Calzolari A; Capanna R; Campanacci D; Caldora P; Masi L; Brandi ML; Zampi G
    J Pathol; 1998 Jul; 185(3):284-9. PubMed ID: 9771482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of TGF-beta and its receptors in murine fetal and adult dermal wounds.
    Cowin AJ; Holmes TM; Brosnan P; Ferguson MW
    Eur J Dermatol; 2001; 11(5):424-31. PubMed ID: 11525949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of TGF beta1 genes and their receptor types I, II, and III in low- and high-grade malignancy non-Hodgkin's lymphomas.
    Woszczyk D; Gola J; Jurzak M; Mazurek U; Mykała-Cieśla J; Wilczok T
    Med Sci Monit; 2004 Jan; 10(1):CR33-7. PubMed ID: 14704634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of TGF-beta-regulated interleukin-8 expression in human prostate cancer cells.
    Lu S; Dong Z
    Prostate; 2006 Jun; 66(9):996-1004. PubMed ID: 16541418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta1 is the predominant isoform required for breast cancer cell outgrowth in bone.
    Mourskaia AA; Dong Z; Ng S; Banville M; Zwaagstra JC; O'Connor-McCourt MD; Siegel PM
    Oncogene; 2009 Feb; 28(7):1005-15. PubMed ID: 19079339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of transforming growth factor-beta1 and transforming growth factor-beta Type-II receptor mRNA in papillary thyroid carcinoma.
    Matoba H; Sugano S; Yamaguchi N; Miyachi Y
    Horm Metab Res; 1998 Oct; 30(10):624-8. PubMed ID: 9851670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor beta isoforms (TGF-beta1, TGF-beta2, TGF-beta3) messenger RNA expression in laryngeal cancer.
    Kapral M; Strzalka B; Kowalczyk M; Jurzak M; Mazurek U; Gierek T; Paluch J; Markowski J; Swiatkowska L; Weglarz L
    Am J Otolaryngol; 2008; 29(4):233-7. PubMed ID: 18598833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of transforming growth factor-beta in transdifferentiation and fibrosis of lens epithelial cells.
    Lee EH; Joo CK
    Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2025-32. PubMed ID: 10440257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta isoform expression during bovine ovarian antral follicle development.
    Nilsson EE; Doraiswamy V; Skinner MK
    Mol Reprod Dev; 2003 Nov; 66(3):237-46. PubMed ID: 14502602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenoviral delivery of an antisense RNA complementary to the 3' coding sequence of transforming growth factor-beta1 inhibits fibrogenic activities of hepatic stellate cells.
    Arias M; Lahme B; Van de Leur E; Gressner AM; Weiskirchen R
    Cell Growth Differ; 2002 Jun; 13(6):265-73. PubMed ID: 12114216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal transforming growth factor-beta expression in mesenchymal stem cells from patients with osteoarthritis.
    Rollín R; Alvarez-Lafuente R; Marco F; García-Asenjo JA; Jover JA; Rodríguez L; López-Durán L; Fernández-Gutiérrez B
    J Rheumatol; 2008 May; 35(5):904-6. PubMed ID: 18398939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced expression of transforming growth factor-beta s and transforming growth factor-beta type II receptor in the synovial tissues of patients with rheumatoid arthritis.
    Taketazu F; Kato M; Gobl A; Ichijo H; ten Dijke P; Itoh J; Kyogoku M; Rönnelid J; Miyazono K; Heldin CH
    Lab Invest; 1994 May; 70(5):620-30. PubMed ID: 8196359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of decorin in esophageal cancer in relation to the expression of three isoforms of transforming growth factor-beta (TGF-beta1, -beta2, and -beta3) and matrix metalloproteinase-2 activity.
    Augoff K; Grabowski K; Rabczynski J; Kolondra A; Tabola R; Sikorski AF
    Cancer Invest; 2009 May; 27(4):443-52. PubMed ID: 19212830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of transforming growth factor beta type I receptor abolishes malignant phenotype of a rat bladder carcinoma cell line.
    Okamoto M; Oyasu R
    Cell Growth Differ; 1997 Aug; 8(8):921-6. PubMed ID: 9269901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.